This study, called The Comparative Effectiveness Dementia & Alzheimer's Registry (CEDAR), is looking at how well different treatments work for Alzheimer's disease (AD) and mild cognitive impairment (MCI). It's an observational study, meaning researchers will watch what happens during your routine medical care. You might receive individualized evidence-based multidomain interventions (education, medications, and non-medication approaches). The study aims to see if these interventions can improve your thinking and memory. Researchers will measure changes in your cognitive (thinking) abilities every six months for 18 months. You can join if you are 18 or older and have a family history of Alzheimer's, memory concerns, or a diagnosis of MCI or early AD. The study is currently unclear on its recruitment status and plans to include about 452 people.

Study design

This is an observational study, meaning researchers will collect information during your regular medical care. It aims to include about 452 participants.

What's involved

Participants will receive individualized evidence-based multidomain interventions as part of their routine outpatient clinical care. Your cognitive abilities will be measured every 6 months.

Compensation

Not stated in the trial record.

Follow-up

Your cognitive abilities will be measured for 18 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.